Home
Facts & Figures
| 5th | in the US for federal research among universities. |
| $1.14 billion |
in research activity annually. |
| 12th | largest US research university in research volume & annual expenditures. |
Our Mission
Cures and treatments for disease. New technologies. New industries for North Carolina and the world. At Carolina, we tackle tough challenges with multidisciplinary teams of top scientists and students whose diverse perspectives deliver creative, unprecedented solutions. As one of America’s top research universities, we conduct roughly $1 billion in research annually. We provide dedicated service to our sponsors and unprecedented opportunities for graduate students, postdocs and undergraduates.
— Terry Magnuson, UNC Vice Chancellor for Research
Strategic Research Priorities
By fostering and supporting collaborative, interdisciplinary teams, UNC Research is accelerating new discoveries and solutions to emerging challenges in these areas:
Brain
Cancer
Data Science
Environment
Opportunity, Well-Being, and Culture
Precision Health and Society
Stories Powered by UNC Research
UNC Researchers Develop PFAS Resin:
UNC-Chapel Hill environmental engineer Orlando Coronell and chemist Frank Leibfarth have developed a filtration resin that has thus far been successful in removing most per-and polyfluoroalkyl substances from water.
Carolina Research in the News | Earlier News Stories…
Calculating COVID-19’s Educational Costs
Cassandra R. Davis studies the impact of natural disasters on schools and communities, particularly at the K-12 level. Now the public policy professor is turning her attention to the impact of a global pandemic on first-generation college students.
Preparing the State for Environmental Threats
The new Center for Resilient Communities and Environment is working with NC communities to understand their vulnerability to increasing environmental threats and develop strategies to strengthen resilience.
UNC Addresses COVID-19 Prevention and Treatment
UNC researchers are working on three areas related to COVID-19 prevention and treatment: a vaccine, an antiviral drug, and monoclonal antibodies, which use cells from recovered patients to help others.